Abcellera Biologics
Price & Volume
Stats
See more52W Range | $1.89-$5.82 |
Market Cap | $1.4B |
Shares Short | 43M |
Financials
See moreRevenue (12 Mos) | $32.8M |
Revenue Growth (YoY) | 133.3% |
Gross Profit (12 Mos) | -$135.8M |
Diluted EPS | -$0.56 |
News
See moreYahoo Finance • 9 days ago
TD Cowen Reiterates Buy Rating on ABCL After AbCellera Biologics Dosed First Participants of ABCL575
Yahoo Finance • last month
KORU Medical Systems And 2 Other Penny Stocks To Watch For Growth
Yahoo Finance • 2 months ago
AbCellera signals clinical-stage transition with first patient dosing for ABCL635 and targets mid-2026 data milestone
Yahoo Finance • 2 months ago
Curious about the stocks that are showing activity after the closing bell on Thursday?
About
CEO | Dr. Carl L.G. Hansen Ph.D. |
Address | 150 West 4th Ave, Vancouver, BC, Canada, V5Y 1G6 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 596 |
